Delivery Order SPE2DB20D1100-SPE2DB25FC6G1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- The Defense Logistics Agency awarded a $1,777.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 12 mg tablets (30-count units), with a completion deadline of June 2, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.80 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 10, 2025 and is not designated with a set-aside. The contract provides for the delivery of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This delivery order, valued at $1,069.74, was awarded on July 14, 2025, to AmerisourceBergen Drug Corp for the supply of Fycompa 12 mg tablets in a 30-count package. The contract is funded by the Defense Logistics Agency (DLA), a defense agency component responsible for medical supply chain management for the Department of Defense. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. Performance will be executed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,149.54 to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count packaging) on June 18, 2025, with completion targeted for June 20, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Fycompa 4 mg tablets (30-count units) with a ceiling value of $4,918.09. This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, represents a non-competitive award with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of FYCOMPA 4 mg tablets (30-count units) with a ceiling value of $3,134.37. This firm fixed-price delivery order, which has an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, valued at $1,489.87 for the supply of Fycompa 2 mg tablets (30-count packages) under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order issued by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $1,457.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count packaging) with a completion date of June 2, 2025. This non-set-aside competitive award represents a single delivery order placed against AmerisourceBergen's broader pharmaceutical supply contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6G1Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of FYCOMPA 12 mg tablets (30-count) with a contract value of $1,051.80. The award is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical supply contract enables the company to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal agencies worldwide. The IDC demonstrates AmerisourceBergen Drug Corp's established capability as a prime pharmaceutical vendor for federal medical procurement, with a portfolio spanning multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/2/25 |